Group 67.png

SoftExpert stands out in the Global Pharmaceutical QMS Market 2025–2030

Published on 26/01/2026

The pharmaceutical industry is navigating an era of increasing regulatory scrutiny, digital transformation, and global process complexity. A recent Research and Markets report on the Pharmaceutical Quality Management Software (QMS) market shows strong momentum: the global market is expected to grow from USD 1.59 billion in 2025 to USD 2.98 billion by 2030, with a compound annual growth rate (CAGR) of 13.3%

This growth reflects how pharma companies are investing in digital tools to ensure compliance, streamline quality processes and improve product safety.

One major trend highlighted in the report is how regulatory compliance is driving QMS adoption, especially as organizations strive to meet global standards like FDA, EMA and WHO guidelines. 

Solutions that automate audits, documentation and compliance workflows help reduce risk and boost operational visibility, a non-negotiable for any modern pharmaceutical quality team.

The report also points out that CAPA management (Corrective and Preventive Actions) is one of the fastest-growing application areas in the market, as companies focus on proactive quality assurance rather than reactive firefighting. This mirrors a broader push toward data-driven quality practices, with automation and analytics woven into core quality processes.

Regionally, Asia Pacific is expected to experience rapid growth, fueled by expanding manufacturing capacities, outsourced clinical trials and alignment with international quality standards.

Key players in the market: where SoftExpert stands

According to the report, the competitive landscape is diverse, with both large international players and specialized solutions shaping the market.

This recognition places SoftExpert alongside global leaders in quality management solutions that support pharmaceutical quality, compliance and digital transformation.

SoftExpert’s enterprise quality management suite is built to manage quality processes end-to-end, from document control and nonconformance tracking to risk management and corrective actions. 
Its modules enable organizations to automate compliance workflows and provide real-time visibility into quality operations, aligning with the market’s shift toward integrated, data-driven quality systems.

Why this matters for Pharma Organizations

The pharmaceutical QMS landscape isn’t growing by accident. Stricter regulatory demands, global supply chains and the need for seamless compliance reporting are pushing life sciences companies to modernize their quality infrastructure. Choosing a solution like SoftExpert that is recognized in such a competitive market underscores a commitment to quality excellence and operational resilience.

 

ABOUT SOFTEXPERT

Operating in the business management software market, SoftExpert emerged in 1995 in southern Brazil. Currently, the brand has over 500 employees, 3,000 customers, 3 million users spread across 50 countries, 300 partners worldwide, including strategic alliances with companies such as AWS, Bakertilly, Deloitte, Kodak Alaris, and DocuSign, in addition to business units in 9 countries. This is because SoftExpert has solutions for companies ranging from business management and corporate quality to environmental, project and government management in just one contract for its customers, providing them with greater efficiency, agility, and cost-effectiveness. Its global presence shows that SoftExpert adapts its range of services according to the needs of companies, as well as their locations. The platform offers a set of multi-language modules that are integrated to automate processes and optimize different business areas of organizations. Follow the standards for your management of all kinds of regulations, like: ISO, FDA, COBIT, COSO, IATF, FSSC, ITL, SOX and many others.